News

Icon for www.nasdaq.comNasdaq · 9d

TScan Therapeutics Announces Abstract Acceptance for Poster Presentation at ASGCT 28th Annual Meeting

Acceptance of an abstract for poster presentation at a prestigious conference highlights TScan Therapeutics' active engagement in the scientific community and ongoing contributions to cancer ...
Icon for www.morningstar.comMorningstar · 9d

Rein Therapeutics Announces Abstract Accepted for Presentation at the American Thoracic Society 2025 International Conference

These 12 undervalued financial-services stocks look attractive today. We sell different types of products and services to both investment professionals and individual investors. These products and ...
The Bakersfield Californian · 12d

Tempus Announces 18 Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025

Tempus is proud to showcase a comprehensive collection of scientific research this year, highlighting the impact of our multimodal dataset and AI-enabled diagnostic solutions on cancer research,” said Kate Sasser,
TMCnet · 12d

Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025

A copy of each poster presentation is available on the Scientific Resources page of the Repare Therapeutics website and a copy of each mini-oral presentation will be available on the Scientific Resources page of the Repare Therapeutics website at the start of each mini-oral session.
Icon for www.nasdaq.comNasdaq · 14d

Affimed N.V. Announces Accepted Abstracts for Oral and Poster Presentations at ASCO 2025 Annual Meeting

Additionally, two abstracts on another drug, AFM24, in combination with atezolizumab for treating non-small cell lung cancer (NSCLC) have been accepted for poster presentations. The oral ...